Manchester, NH, United States of America

John Leonard

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Leonard. Retrieved from https://idiyas.com/inventor/john-leonard-knyotg9c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John Leonard

Introduction

John Leonard is an accomplished inventor based in Manchester, NH (US). He has made significant contributions to the field of medicine, particularly in the treatment of metabolic diseases. His innovative work has the potential to impact the lives of many patients suffering from various conditions.

Latest Patents

John Leonard holds a patent for glucosylceramide synthase inhibitors. This invention relates to inhibitors of glucosylceramide synthase (GCS) represented by a specific structural formula or a pharmaceutically acceptable salt thereof. These inhibitors are useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, as well as for the treatment of cancer.

Career Highlights

Leonard is associated with Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Elyse Bourque and Mario A Cabrera-Salazar. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

John Leonard's contributions to the field of medicine through his patent for glucosylceramide synthase inhibitors exemplify the impact of innovation on healthcare. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…